The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage

被引:13
|
作者
White, C. Roger [1 ]
Datta, Geeta [1 ]
Wilson, Landon [3 ]
Palgunachari, Mayakonda N. [1 ]
Anantharamaiah, G. M. [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Targeted Metabol & Prote Lab, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
ApoA-I; ApoA-I mimetic peptide; Hypochlorous acid; Oxidation; Cholesterol efflux; HIGH-DENSITY-LIPOPROTEIN; CORONARY ATHEROSCLEROSIS; HDL; NANOPARTICLES; CHOLESTEROL; DISEASE; MILANO;
D O I
10.1016/j.chemphyslip.2019.01.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High density lipoprotein (HDL) is prone to modification by the oxidizing and chlorinating agent hypochlorite anion (OCl-). Oxidation of apolipoprotein (apo) A-I, the major protein in HDL, reduces ABCA-1 mediated cholesterol efflux and other protective responses to HDL. The apoA-I mimetic peptide 4F has been shown to undergo oxidation; however, the ability of the peptide to mediate cholesterol efflux remains intact. Here, we show that 4F protects apoA-I from hypochlorite-mediated oxidation. Mass spectral analysis of apoA-I shows that tyrosine residues that are prone to hypochlorite-mediated chlorination are protected in the presence of 4F. Furthermore, 4F enhances the cholesterol efflux ability of apoA-I to a greater extent than either 4F or apoA-I alone, even after hypochlorite oxidation. These observations suggest that apoA-I in lipid complexes may be protected by the presence of 4F, resulting in the preservation of its anti-inflammatory and anti-atherogenic properties. These studies also form the basis for the future studies of nanoparticles possessing both apoA-I and 4F.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [1] The Role of Apolipoprotein A-I and 4F, an ApoA-I Mimetic, in Attenuation of Pulmonary Inflammation and Airway Hyperresponsiveness
    Wang, Weiling
    Xu, Hao
    Shi, Yang
    Nandedkar, Sandhya
    Zhang, Hao
    Sorci-Thomas, Mary
    Pritchard, Kirkwood A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E277 - E277
  • [2] Molecular Dynamics Simulations of Apolipoprotein A-I Peptide Mimetic 4F
    Plain, Amanda M.
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 379A - 380A
  • [3] Bioenergetic programming of macrophages by the apolipoprotein A-I mimetic peptide 4F
    Datta, Geeta
    Kramer, Philip A.
    Johnson, Michelle S.
    Sawada, Hirotaka
    Smythies, Lesley E.
    Crossman, David K.
    Chacko, Balu
    Ballinger, Scott W.
    Westbrook, David G.
    Mayakonda, Palgunachari
    Anantharamaiah, G. M.
    Darley-Usmar, Victor M.
    White, C. Roger
    BIOCHEMICAL JOURNAL, 2015, 467 : 517 - 527
  • [4] Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F
    White, C. Roger
    Datta, Geeta
    Buck, Amanda K. W.
    Chaddha, Manjula
    Reddy, Gautam
    Wilson, Landon
    Palgunachari, Mayakonda N.
    Abbasi, Mohammad
    Anantharamaiah, G. M.
    JOURNAL OF LIPID RESEARCH, 2012, 53 (08) : 1576 - 1587
  • [5] ApoA-I Mimetic Peptide 4F Inhibits Inflammatory Bowel Disease in Mice
    Meriwether, David
    Volpe, Carmen
    Grijalva, Victor
    Mukherjee, Pallavi
    Martin, Martin
    Anantharamaiah, G. M.
    Fogelman, Alan M.
    Reddy, Srinivasa T.
    CIRCULATION, 2016, 134
  • [6] Synthetic apolipoprotein A-I mimetic peptide 4F protects hearts and kidneys after myocardial infarction
    Moreira, Roberto S.
    Irigoyen, Maria C.
    Capcha, Jose M. C.
    Sanches, Talita R.
    Gutierrez, Paulo S.
    Garnica, Margoth R.
    Noronha, Irene de L.
    Andrade, Lucia
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY, INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2020, 318 (03) : R529 - R544
  • [7] Effects of apolipoprotein A-I mimetic peptide 4F on human RPE cells
    Brinkmann, Max
    Dietrich, Eva
    Koehler, Franziska
    Grisanti, Salvatore
    Rudolf, Martin
    Ranjbar, Mahdy
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [8] Regulation of Pattern Recognition Receptors by the Apolipoprotein A-I Mimetic Peptide 4F
    White, C. Roger
    Smythies, Lesley E.
    Crossman, David K.
    Palgunachari, Mayakonda N.
    Anantharamaiah, G. M.
    Datta, Geeta
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (11) : 2631 - +
  • [9] Oxidized fatty acids and inflammatory response in acne: A potential therapeutic role for apolipoprotein A-I (apoA-I) mimetic peptide 4F as an anti-inflammatory agent
    Pirouz, A.
    Qin, M.
    Fogelman, A. M.
    Kim, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S15 - S15
  • [10] Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer
    Su, Feng
    Kozak, Kathy R.
    Imaizumi, Satoshi
    Gao, Feng
    Amneus, Malaika W.
    Grijalva, Victor
    Ng, Carey
    Wagner, Alan
    Hough, Greg
    Farias-Eisner, Gina
    Anantharamaiah, G. M.
    Van Lenten, Brian J.
    Navab, Mohamad
    Fogelman, Alan M.
    Reddy, Srinivasa T.
    Farias-Eisner, Robin
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (46) : 19997 - 20002